{
    "organizations": [],
    "uuid": "21d189e9895fb83edb9990443e0346b7b5adb3f4",
    "author": "",
    "url": "https://www.reuters.com/article/brief-amag-gets-fda-approval-of-makena-s/brief-amag-gets-fda-approval-of-makena-subcutaneous-auto-injector-idUSASB0C5UK",
    "ord_in_thread": 0,
    "title": "BRIEF-AMAG Gets FDA Approval Of Makena Subcutaneous Auto-Injector",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Amag Pharmaceuticals Inc:\n* AMAG PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF MAKENA® (HYDROXYPROGESTERONE CAPROATE INJECTION) SUBCUTANEOUS AUTO-INJECTOR TO REDUCE THE RISK OF PRETERM BIRTH IN CERTAIN AT-RISK WOMEN\n* AMAG PHARMACEUTICALS - EXPECTS TO FILE A NEW DRUG APPLICATION THIS QUARTER FOR A NEW CHEMICAL ENTITY (BREMELANOTIDE) ​\n* AMAG PHARMACEUTICALS INC - ‍EXPECTS SUBCUTANEOUS AUTO-INJECTOR TO BE AVAILABLE IN SECOND HALF OF MARCH​\n* AMAG PHARMACEUTICALS INC - WILL CONTINUE TO OFFER IM FORMULATION OF MAKENA IN BOTH SINGLE-DOSE AND MULTI-DOSE VIALS​\n* AMAG PHARMACEUTICALS INC - ‍MAKEN‘S 7-YEAR ORPHAN DRUG EXCLUSIVITY EXPIRED EARLIER THIS MONTH​\n* AMAG PHARMACEUTICALS - ANNOUNCES FDA APPROVAL OF MAKENA (HYDROXYPROGESTERONE CAPROATE INJECTION) SUBCUTANEOUS AUTO-INJECTOR ‍​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-15T01:24:00.000+02:00",
    "crawled": "2018-02-15T01:45:58.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "amag",
        "pharmaceutical",
        "inc",
        "amag",
        "pharmaceutical",
        "announces",
        "fda",
        "approval",
        "hydroxyprogesterone",
        "caproate",
        "injection",
        "subcutaneous",
        "reduce",
        "risk",
        "preterm",
        "birth",
        "certain",
        "woman",
        "amag",
        "pharmaceutical",
        "expects",
        "file",
        "new",
        "drug",
        "application",
        "quarter",
        "new",
        "chemical",
        "entity",
        "bremelanotide",
        "amag",
        "pharmaceutical",
        "inc",
        "subcutaneous",
        "available",
        "second",
        "half",
        "amag",
        "pharmaceutical",
        "inc",
        "continue",
        "offer",
        "im",
        "formulation",
        "makena",
        "amag",
        "pharmaceutical",
        "inc",
        "orphan",
        "drug",
        "exclusivity",
        "expired",
        "earlier",
        "amag",
        "pharmaceutical",
        "announces",
        "fda",
        "approval",
        "makena",
        "hydroxyprogesterone",
        "caproate",
        "injection",
        "subcutaneous",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}